Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
14%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
PPH
27
HOLDINGS
54%
ALSO IN XPH
XPH
60
HOLDINGS
22%
ALSO IN PPH
SECTOR DRIFT (PPH minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
BRISTOL-MYERS SQUIBB CO | 4.8% | 1.7% | 1.7% |
|
JOHNSON & JOHNSON | 4.5% | 1.7% | 1.7% |
|
MERCK & CO. INC. | 9.9% | 1.7% | 1.7% |
|
ELI LILLY & CO | 20.0% | 1.6% | 1.6% |
|
PFIZER INC | 4.5% | 1.5% | 1.5% |
PPH Overweight Relative to XPH
|
ELI LILLY & CO | 18.4% |
 |
NOVARTIS AG-ADR | 10.4% |
|
MERCK & CO. INC. | 8.3% |
 |
NOVO-NORDISK A/S-SPONS ADR | 5.4% |
|
ABBVIE INC | 4.7% |
|
MCKESSON CORP | 4.5% |
 |
GLAXOSMITHKLINE PLC-SPON ADR | 4.3% |
 |
SANOFI-AVENTIS-ADR | 4.0% |
|
ASTRAZENECA PLC-SPONS ADR | 3.8% |
|
CENCORA INC | 3.6% |
PPH Underweight Relative to XPH
|
CRINETICS PHARMACEUTICALS INC | -3.7% |
|
MBX BIOSCIENCES INC | -3.0% |
|
DEFINIUM THERAPEUTICS INC | -2.8% |
|
ENLIVEN THERAPEUTICS, INC. | -2.2% |
|
NUVATION BIO INC CLASS A | -2.1% |
|
ALUMIS INC | -2.1% |
|
AMYLYX PHARMACEUTICALS, INC. | -2.1% |
|
LIQUIDIA TECHNOLOGIES, INC. | -2.0% |
|
TREVI THERAPEUTICS, INC. | -2.0% |
|
EDGEWISE THERAPEUTICS, INC. | -1.9% |